29 citations
,
February 2022 in “Frontiers in Cell and Developmental Biology”
This review discusses strategies to improve CRISPR/Cas systems by addressing limitations like off-target effects and delivery inefficiencies, offering practical guidance and highlighting future applications, but reports no new research findings.
1 citations
,
April 2023 in “International Journal of Molecular Sciences”
This review discusses advances in CRISPR/Cas9variants and nanoformulations for cancer treatment, noting challenges and prospects for clinical application, but reports no new research results.
This study discusses the transformative potential of gene editing technologies, such as CRISPR-Cas9, for personalized aesthetic interventions in dermatology, but highlights the need for rigorous safety measures, ethical considerations, and careful regulatory oversight before clinical application.
21 citations
,
January 2022 in “Biomaterials Science”
This article reviews CRISPR/Cas system delivery methods for genome editing and highlights RNA's promise in non-viral in vivo applications but reports no new clinical results.